IBRX
ImmunityBio, Inc. · Search Wikipedia for ImmunityBio, Inc. · Yahoo Finance chart ↗
Price
- Last close
- $8.29Last update Oct 30, 2026
- 12-month high
- $12.43
- 12-month low
- $1.95
Some historical prices are missing. High and low cover the available dates.
Reported holders
Politicians whose newest complete holdings report lists this stock, or who reported buying it after that report (or at any time, if they have no usable report). A later full sale that could have closed the position removes them.
| Name | Purchased | Price that day | ROI |
|---|---|---|---|
| Lisa McClain Rank #2 | Sep 30, 2026 | $9.44 | -12.18% |
Prices are the market close on the purchase date; exact purchase prices are not disclosed. ROI is the percentage gain or loss from that price to the last close.
All trades
| Ticker | Politician Name | Transaction Type | Trade Date | Found Date |
|---|---|---|---|---|
| IBRX — ImmunityBio, Inc. - Common Stock (IBRX) [ST], Lisa McClain, purchase, Sep 30, 2026 | Lisa McClain Rank #2 | Purchase | Sep 30, 2026 | Oct 19, 2026 |
| IBRX — ImmunityBio, Inc. - Common Stock (IBRX) [ST], Lisa McClain, purchase, Sep 28, 2026 | Lisa McClain Rank #2 | Purchase | Sep 28, 2026 | Oct 19, 2026 |
| IBRX — ImmunityBio, Inc. (IBRX) [ST], Daniel Goldman, sale, Mar 6, 2023 | Daniel Goldman Rank #76 | Sale | Mar 6, 2023 | Sep 12, 2026 |